US FDA alerts health care providers of recall of anemia drug Omontys – In US, Omontys Injection is recalled due to reports of anaphylaxis, a serious and life-threatening allergic reaction. Omontys is used to treat anemia in adult dialysis patients. Until further notice, health care providers should stop using Omontys.
Baxter Enhances Renal Therapies Portfolio with Acquisition of Gambro — Acquisition Expands Baxter’s Role as Global Provider of Dialysis Products – Baxter International Inc. (NYSE:BAX) has entered into a definitive agreement to acquire Gambro AB, a privately held dialysis product company based in Lund, Sweden, for total consideration of 26.5 billion SEK (approximately $4.0 billion USD at current exchange rates).
Kidney transplanted twice in 2 weeks — Transplant recipient donates kidney after disease threatens the organ; re-implantation reverses damage and allows another patient to thrive – For the first time, a kidney that had been donated to a patient in need was removed and implanted into a new patient, the third individual to have the organ, after it failed in the first transplant recipient.
Depression may increase the risk of kidney failure – Depression is associated with an increased risk of developing kidney failure in the future, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).
Sleep loss linked to increase in Alzheimer’s plaques – Neurodegenerative disorders like Alzheimer’s disease and Parkinson’s disease often disrupt sleep. The new researches indicate that sleep loss could play a role in the genesis of such disorders.
Hello wearable kidney, goodbye dialysis machine — Wearable Artificial Kidney for dialysis patients. – Researchers are developing a Wearable Artificial Kidney for dialysis patients, reports an upcoming paper in the Clinical Journal of the American Society of Nephrology (CJASN).
Chemical found in medical devices impairs heart function – Researchers at the Johns Hopkins University School of Medicine have found that a chemical commonly used in the production of such medical plastic devices as intravenous (IV) bags and catheters can impair heart function in rats.
Shorter wait means longer life for kidney transplant candidates – How long a patient survives after a kidney transplant could depend on where he or she signs up to get the surgery, new research from the University of Florida shows.
Guideline alert for blood pressure patients as treatment combo fails (combination of ACE inhibitors and Angiotensin II Receptor Blockers) – Thousands of Canadians with high blood pressure (hypertension) are being treated with a drug combination that increases the risk of sudden cardiac death, kidney disease and the likelihood of dialysis, warns the Heart and Stroke Foundation.
Electromagnetic interference from some identification devices like radio frequency identification devices RFID may pose hazards to critical care medical equipments in hospitals. – The use of radio frequency identification devices RFID appears to have the potential to cause critical care medical equipment to malfunction. Electromagnetic interference from these identification devices pose hazards to critical care medical equipments in hospitals and nursing homes.
New Zealanders who were given the intravenous medication, heparin, can be reassured contaminated products found overseas have not been supplied to the New Zealand market. – New Zealanders who were given the intravenous medication, heparin, can be reassured contaminated products found overseas have not been supplied to the New Zealand market, reported by Medsafe, New Zealand.
MIT reseachers have explained how contaminated batches of the blood-thinner heparin were able to slip past traditional safety screens. – An international team of researchers led by Massachusetts institute of technology (MIT) has explained how contaminated batches of the blood-thinner heparin were able to slip past traditional safety screens and kill dozens of patients recently in the United States and Germany.